Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × etoposide phosphate × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 4 Sarcoma, Ewing 2 Rhabdoid Tumor 2 Medulloblastoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Ganglioneuroblastoma 2 Ependymoma 2 Brain Neoplasms 2 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Pinealoma 1 Osteosarcoma 1 Nervous System Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Enteropathy-Associated T-Cell Lymphoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06230224 2026-02-06

OLYMPIA-4

Regeneron Pharmaceuticals

Phase 3 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡